ASHLEY GILMORE: Open Payments
NPI 1457011835 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 18 payments from 9 companies in 2025. Trend: 2023 $659 · 2024 $443 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 5 | $137 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Amgen Inc. | 2 | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: Assure WCD, LEQVIO, JARDIANCE, CAMZYOS, Repatha, LifeVest, VERQUVO, Wegovy.
Industry payments across FL — which companies pay providers there.
